^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Melblez Kit (melphalan hepatic delivery system)

    i
    Other names: Chemostat melphalan, Delcath Hepatic Chemostat Delivery System for melphalan, CS-PHP-melphalan, melphalan drug delivery system, Generation Two Chemostat Delivery System for melphalan, melphalan/HDS, Chemosat
    Company:
    Delcath, Medac
    Drug class:
    DNA synthesis inhibitor
    Related drugs:
    2ms
    Evaluation of the Safety and Efficacy of Treatment W/High Dose Melphalan Given Directly Into the Liver Followed by Treatment W/approved Cancer Treatment or Approved Cancer Treatment Alone in Patients W/ Metastatic Colorectal Cancer W/liver Dominant Disease (clinicaltrials.gov)
    P2, N=90, Not yet recruiting, Delcath Systems Inc.
    New P2 trial
    |
    Avastin (bevacizumab) • Lonsurf (trifluridine/tipiracil) • Melblez Kit (melphalan hepatic delivery system)
    11ms
    An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma (clinicaltrials.gov)
    P3, N=30, Active, not recruiting, Delcath Systems Inc. | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    Melblez Kit (melphalan hepatic delivery system)
    11ms
    FOCUS: Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma (clinicaltrials.gov)
    P3, N=102, Completed, Delcath Systems Inc. | Active, not recruiting --> Completed | Trial completion date: May 2025 --> Aug 2023
    Trial completion • Trial completion date
    |
    Melblez Kit (melphalan hepatic delivery system)